Melanoma Chemotherapy Leads to the Selection of ABCB5-Expressing Cells

Marine Chartrain; Joëlle Riond; Aline Stennevin; Isabelle Vandenberghe; Bruno Gomes; Laurence Lamant; Nicolas Meyer; Jean Edouard Gairin; Nicolas Guilbaud; Jean Philippe Annereau

doi:10.1371/journal.pone.0036762

Loading metrics

Open Access

Peer-reviewed

Research Article

Melanoma Chemotherapy Leads to the Selection of ABCB5-Expressing Cells

Marine Chartrain ,

Contributed equally to this work with: Marine Chartrain, Joëlle Riond

Affiliations UMR 2587, CNRS-Pierre Fabre, Institut des Sciences et Technologies du Médicament de Toulouse (ISTMT), Toulouse, France, Centre de Recherche en Oncologie Expérimentale, Centre de Recherche et Développement Pierre Fabre - Toulouse Langlade, Toulouse, France
⨯
Joëlle Riond ,

Contributed equally to this work with: Marine Chartrain, Joëlle Riond

* E-mail: joelle.riond@dr14.cnrs.fr

Affiliations UMR 2587, CNRS-Pierre Fabre, Institut des Sciences et Technologies du Médicament de Toulouse (ISTMT), Toulouse, France, USR 3388, CNRS-Pierre Fabre, Centre de Recherche et Développement Pierre Fabre - Toulouse Langlade, Toulouse, France
⨯
Aline Stennevin,

Affiliation Centre de Recherche en Oncologie Expérimentale, Centre de Recherche et Développement Pierre Fabre - Toulouse Langlade, Toulouse, France
⨯
Isabelle Vandenberghe,

Affiliation Centre de Recherche en Oncologie Expérimentale, Centre de Recherche et Développement Pierre Fabre - Toulouse Langlade, Toulouse, France
⨯
Bruno Gomes,

Affiliation Centre de Recherche en Oncologie Expérimentale, Centre de Recherche et Développement Pierre Fabre - Toulouse Langlade, Toulouse, France
⨯
Laurence Lamant,

Affiliation INSERM U563, CHU Purpan, Toulouse, France
⨯
Nicolas Meyer,

Affiliation Hôpital Larrey, Toulouse, France
⨯
Jean Edouard Gairin,

Affiliations UMR 2587, CNRS-Pierre Fabre, Institut des Sciences et Technologies du Médicament de Toulouse (ISTMT), Toulouse, France, UMR152 IRD-UPS “PHARMA-DEV”, Faculté de Pharmacie - Université Toulouse III - Paul Sabatier, Toulouse, France
⨯
Nicolas Guilbaud,

Affiliation Centre de Recherche en Oncologie Expérimentale, Centre de Recherche et Développement Pierre Fabre - Toulouse Langlade, Toulouse, France
⨯
Jean Philippe Annereau

Affiliation Centre de Recherche en Oncologie Expérimentale, Centre de Recherche et Développement Pierre Fabre - Toulouse Langlade, Toulouse, France
⨯

Melanoma Chemotherapy Leads to the Selection of ABCB5-Expressing Cells

Marine Chartrain,
Joëlle Riond,
Aline Stennevin,
Isabelle Vandenberghe,
Bruno Gomes,
Laurence Lamant,
Nicolas Meyer,
Jean Edouard Gairin,
Nicolas Guilbaud,
Jean Philippe Annereau

Published: May 24, 2012
https://doi.org/10.1371/journal.pone.0036762

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Melanoma
Is the Subject Area "Melanoma" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Flow cytometry
Is the Subject Area "Flow cytometry" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Melanoma cells
Is the Subject Area "Melanoma cells" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.